Who are Intradetrusor Botox Injections's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Botulinum Toxin Type A 900kDa, Radiesse, Xeomin, Belotero, Botulinum Toxin-A injection, Botulinum Toxin Type A 900kD, Botox infiltration, botulinum type a.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/intradetrusor-botox-injections.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Intradetrusor Botox Injections — Competitive Intelligence Brief

Intradetrusor Botox Injections (Intradetrusor Botox Injections) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Neurotoxin; botulinum toxin type A. Area: Urology; Neurology.

marketed Neurotoxin; botulinum toxin type A SNARE complex (synaptosomal-associated protein); acetylcholine release machinery Urology; Neurology Biologic Live · refreshed every 30 min

Target snapshot

Intradetrusor Botox Injections (Intradetrusor Botox Injections) — The Methodist Hospital Research Institute. Botulinum toxin injected into the detrusor muscle blocks acetylcholine release at the neuromuscular junction, reducing involuntary bladder contractions.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Intradetrusor Botox Injections TARGET	Intradetrusor Botox Injections	The Methodist Hospital Research Institute	marketed	Neurotoxin; botulinum toxin type A	SNARE complex (synaptosomal-associated protein); acetylcholine release machinery
Botulinum Toxin Type A 900kDa	Botulinum Toxin Type A 900kDa	Allergan	marketed	Neurotoxin; acetylcholine release inhibitor	SNAP-25 (synaptosome-associated protein of 25 kDa)
Radiesse, Xeomin, Belotero	Radiesse, Xeomin, Belotero	Main Line Center for Laser Surgery	marketed	Dermal fillers and neurotoxin
Botulinum Toxin-A injection	Botulinum Toxin-A injection	Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust	marketed	Neurotoxin; neuromuscular blocking agent	SNARE complex (specifically cleaves SNAP-25)
Botulinum Toxin Type A 900kD	Botulinum Toxin Type A 900kD	Allergan	marketed	Neurotoxin; acetylcholine release inhibitor	SNAP-25 (synaptosome-associated protein of 25 kDa)
Botox infiltration	Botox infiltration	University Rovira i Virgili	marketed	Neurotoxin; botulinum toxin type A	SNARE complex (synaptosome-associated protein); acetylcholine release machinery
botulinum type a	botulinum type a	Henry Ford Health System	marketed	Neurotoxin; botulinum toxin	SNARE proteins (synaptobrevin, SNAP-25, syntaxin); acetylcholine release machinery

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Neurotoxin; botulinum toxin type A class)

Galderma R&D · 1 drug in this class
The Methodist Hospital Research Institute · 1 drug in this class
University Hospital, Clermont-Ferrand · 1 drug in this class
University Rovira i Virgili · 1 drug in this class
Women and Infants Hospital of Rhode Island · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Intradetrusor Botox Injections — Competitive Intelligence Brief. https://druglandscape.com/ci/intradetrusor-botox-injections. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab